The role of transporters on drug therapy

ABSTRACT Pharmacodynamical studies showed that most drugs elicit their effects by acting on 3 kinds of protein molecules known as receptors, enzymes or transporters. Although their detail properties had not been explained for decades the roles of transporters in drug kinetics and dynamics has been...

Full description

Bibliographic Details
Main Author: . Ngatidjan
Format: Article
Language:English
Published: Universitas Gadjah Mada 2016-02-01
Series:Journal of the Medical Sciences
Online Access:https://jurnal.ugm.ac.id/bik/article/view/9209
id doaj-a39ec5f036144ba1b3a8c358e3730b43
record_format Article
spelling doaj-a39ec5f036144ba1b3a8c358e3730b432020-11-24T23:31:18ZengUniversitas Gadjah MadaJournal of the Medical Sciences0126-13122356-39312016-02-01470110.19106/JMedSci0047012015067439The role of transporters on drug therapy. NgatidjanABSTRACT Pharmacodynamical studies showed that most drugs elicit their effects by acting on 3 kinds of protein molecules known as receptors, enzymes or transporters. Although their detail properties had not been explained for decades the roles of transporters in drug kinetics and dynamics has been well understood, even have been applied in the therapy. Transporters are classified into 2 major classes, the solute carriers (SLC) and ATP-binding cassette (ABC) families. SLC transporters do not possess ATP binding site property as those of ABC transporters. SLC transporters consist of 3 SLC subfamilies i.e. organic cation transporters (OCTs), organic anion transporters (OATs) and organic anion transporting polypeptides (OATPs). In contrast, ABC transporters require ATP hydrolysis to transport substrate across cell membrane. Human ABC-transporters consist of ABCA1- 13, ABCB1-11, ABCC1-12, ABCD1-4, ABCE1, ABCF1-3 and ABCG1-8 subfamily. Although the originally funtion of transporter is to transport specific physiological substrate such as nutrient, hormone, cytokines, neurotransmitters and other physiological subtances across cell membrane the specificity is not restricted to each substrate. Drugs and other xenobiotics which have structural similarity to the physiological substrates are recognized and transported by the related transporters. The competition of them on transporters therefore may lead to the occurence of drug-drug interactions (DDI) or drugphysiological substrate interaction in the drug-kinetics phase. Many transporters located in the liver, intestinal and renal epithelial cell membranes involve in the transport of endogenous substance or xenobiotics including drugs play important roles as protective barrier. Since transporters also serve as the targets of drug action it is understood that transporters play important role in the pathogenesis of diseases as well as in the drug therapy of diseases.https://jurnal.ugm.ac.id/bik/article/view/9209
collection DOAJ
language English
format Article
sources DOAJ
author . Ngatidjan
spellingShingle . Ngatidjan
The role of transporters on drug therapy
Journal of the Medical Sciences
author_facet . Ngatidjan
author_sort . Ngatidjan
title The role of transporters on drug therapy
title_short The role of transporters on drug therapy
title_full The role of transporters on drug therapy
title_fullStr The role of transporters on drug therapy
title_full_unstemmed The role of transporters on drug therapy
title_sort role of transporters on drug therapy
publisher Universitas Gadjah Mada
series Journal of the Medical Sciences
issn 0126-1312
2356-3931
publishDate 2016-02-01
description ABSTRACT Pharmacodynamical studies showed that most drugs elicit their effects by acting on 3 kinds of protein molecules known as receptors, enzymes or transporters. Although their detail properties had not been explained for decades the roles of transporters in drug kinetics and dynamics has been well understood, even have been applied in the therapy. Transporters are classified into 2 major classes, the solute carriers (SLC) and ATP-binding cassette (ABC) families. SLC transporters do not possess ATP binding site property as those of ABC transporters. SLC transporters consist of 3 SLC subfamilies i.e. organic cation transporters (OCTs), organic anion transporters (OATs) and organic anion transporting polypeptides (OATPs). In contrast, ABC transporters require ATP hydrolysis to transport substrate across cell membrane. Human ABC-transporters consist of ABCA1- 13, ABCB1-11, ABCC1-12, ABCD1-4, ABCE1, ABCF1-3 and ABCG1-8 subfamily. Although the originally funtion of transporter is to transport specific physiological substrate such as nutrient, hormone, cytokines, neurotransmitters and other physiological subtances across cell membrane the specificity is not restricted to each substrate. Drugs and other xenobiotics which have structural similarity to the physiological substrates are recognized and transported by the related transporters. The competition of them on transporters therefore may lead to the occurence of drug-drug interactions (DDI) or drugphysiological substrate interaction in the drug-kinetics phase. Many transporters located in the liver, intestinal and renal epithelial cell membranes involve in the transport of endogenous substance or xenobiotics including drugs play important roles as protective barrier. Since transporters also serve as the targets of drug action it is understood that transporters play important role in the pathogenesis of diseases as well as in the drug therapy of diseases.
url https://jurnal.ugm.ac.id/bik/article/view/9209
work_keys_str_mv AT ngatidjan theroleoftransportersondrugtherapy
AT ngatidjan roleoftransportersondrugtherapy
_version_ 1725538480984948736